Articles

In today’s pharmaceutical industry there is a sharp focus on the needs and requirements of the patient. More and more drugs are being developed for specific patient groups.Orphan drugs, for example,may require small batch sizes ranging anywhere from 500...

Pharmaceutical service provider is focused on sustainability The history of Vetter started with a simple pharmacy. This late Gothic, half-timbered house in Ravensburg's city center is a reminder of these first entrepreneurial steps taken by the founder, Senator h.c. Helmut...

Karen Ooms at Quanticate explains why clinical trial data alone is not enough to truly understand a drug’s effectiveness and argues that real-world data (RWD) is the key to filling the gap. Randomized clinical trials have long been a...

How Global Trends Are Driving Patient-Centricity in Parenteral Products. Parenteral products represent a major growth engine in today’s surging global biopharma market. Their share of the global market figures to grow from 53% in 2020 ($606bn) to 57% in 2027...

With more vaccines being approved worldwide, maintaining the shipments’ integrity throughout the delivery process is the most challenging hurdle for many logistics providers. Since the first COVID-19 vaccine was approved in December last year – Pfizer-BioNTech’s mRNA vaccine – there...

Generating insights about patients on specialty therapies through data aggregation and integration can improve patient outcomes As the number of specialty drugs expands in complex disease areas, such as autoimmune, multiple sclerosis, oncology, and respiratory illnesses, pharmaceutical companies have shown...

The growing demand for increased tablet quantities and the goal of reducing time to market is putting pressure on manufacturers to produce quality tablets in record time. This calls for the implementation of efficient procedures, quality equipment and an...